S-1 Filing

Company

ZyVersa Therapeutics, Inc.

Filed

December 21, 2022

Accession Number

0001493152-22-036164

An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →